Navigation Links
Cellceutix Reports Confidential Disclosure Agreement Signed With Major Pharmaceutical Company
Date:3/8/2011

BEVERLY, Mass., March 8, 2011 /PRNewswire/ -- Cellceutix Corporation (Pink Sheets: CTIX) today disclosed that it has entered into a Confidential Disclosure Agreement (CDA) pertaining to its anti-cancer drug, Kevetrin™, with one of the world's largest pharmaceutical companies.

Cellceutix CEO, Leo Ehrlich, commented, "It's relatively uncommon for big pharma to be signing a CDA on a compound before clinical trials are underway.  The process begins with Cellceutix providing non-confidential information to the other party.  If after review of the materials the interest remains high, they will request to enter into a CDA.   We are glad that their interpretation of the Kevetrin™ studies was sufficient to warrant entering into a CDA with Cellceutix."  Mr. Ehrlich continued, "Signing a CDA does not mean a licensing deal or other transaction is imminent and makes no assumptions that it ever will.  But, conversely, a deal won't ever happen without first signing a CDA.  At Cellceutix, we are focused on moving our compounds toward clinical trials and maximizing shareholders' value.  This agreement is one more step in that process."

Cellceutix has previously reported that in animal studies Kevetrin™ has shown potent anti-tumor activity against many different cancers including lung, breast and colon cancers as well as leukemia and various strains for which current drugs are ineffective ("drug-resistant cancers").  Data released over the last week by Cellceutix has also shown that Kevetrin™ demonstrates characteristics that are seen as highly desirable in a new chemotherapy as it has not only shown to be non-genotoxic, but also reactivates p53, the "Guardian Angel Protein."    

About Cellceutix

Cellceutix Corporation is a preclinical cancer, anti-inflammatory and autism drug developer. 
'/>"/>

SOURCE Cellceutix Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cellceutix Discovers Drug Activates Guardian Angel p53 in Fight Against Leukemia
2. Cellceutix Cancer Drug Kevetrin™ Shows No Genotoxicity in Study
3. Sequenom Reports Fourth Quarter and Full Year 2010 Financial Results
4. Cumberland Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
5. RBC Life Sciences Reports Sales and Earnings Growth in 2010
6. Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2010 Results
7. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
8. IRIDEX Reports Strong Growth and Profits in 2010 Fourth Quarter
9. China Pharma Holdings, Inc. Reports Full Year 2010 Financial Results
10. Sequenom Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
11. Assured Pharmacy Reports Same Store Sales for the Month of December 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... Aug. 27, 2015 WuXi PharmaTech (Cayman) Inc. ... technology platform company serving the pharmaceutical, biotechnology, ... process development and manufacturing subsidiary Shanghai SynTheAll ... approval from the Japan PMDA for the ... branded commercial drug in July. STA is ...
(Date:8/27/2015)... CAMBRIDGE, Mass. , Aug. 27, 2015 Oryzon ... & Renshaw 17th Annual Global Investment Conference in ... Hotel, ORYZON will be represented by President and CEO ... Dr. Buesa will present this information on Thursday September ... (2nd Floor).  The company is completing preclinical development of its ...
(Date:8/26/2015)... NEW YORK , Aug. 26, 2015 The ... a CAGR of 7.0% between 2014 and 2019. Although ... Computerized Physician Order Entry market, India ... the forecast period in this regional market. The increasing demand ... government bodies for implementation of these systems in healthcare facilities ...
Breaking Medicine Technology:WuXi PharmaTech's STA Subsidiary Receives First Approval from Japanese Regulatory Authorities 2ORYZON to Present at Rodman & Renshaw 17th Annual Global Investment Conference 2ORYZON to Present at Rodman & Renshaw 17th Annual Global Investment Conference 3ORYZON to Present at Rodman & Renshaw 17th Annual Global Investment Conference 4Asian Computerized Physician Order Entry Market by Product, by Deployment, by Component -Forecast to 2019 2Asian Computerized Physician Order Entry Market by Product, by Deployment, by Component -Forecast to 2019 3
... vitro microbiology and proof of concept in topical ... March 2007 - Arpida Ltd.,(SWX: ARPN) today announced ... against a large panel of,clinical isolates, including those ... of AR-2474 were found,to be highly effective in ...
... Autism Association calls 2006 Pediatrics study fatally,flawed, CHICAGO, ... at a National Autism Association meeting,bolster claims that ... of,autism spectrum disorders. David Ayoub, MD presented data,suggesting ... pervasive developmental disorder (PDD), a form of autism,in ...
Cached Medicine Technology:Arpida adds novel antibiotic AR-2474 to its preclinical pipeline 2Arpida adds novel antibiotic AR-2474 to its preclinical pipeline 3Newly Released Canadian Data Links Vaccines with Pervasive,Developmental Disorder 2
(Date:8/27/2015)... ... August 27, 2015 , ... More destinations and stores are becoming pet-friendly, ... Amica Insurance is sharing some tips to help your whole family travel safely and ... travel with pets each year. Amica is sharing the following tips from the American ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... for quality market research promotion on the Internet. MarketPublishers.com is now authorised ... Commenting on the partnership agreement, Natalie Aster, Assistant Manager at Partners Department, ...
(Date:8/27/2015)... , ... August 27, 2015 , ... ... Hope and Innovation has grown to having twelve offices in three counties, LA, ... hospitals in the Southern California region. Founded by Dr. Richy Agajanian, the ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... firm that helps libraries, publishers and companies leverage key operational, technical, business ... the VIVO Project. Gunter Media Group, Inc., will provide VIVO related services ...
(Date:8/27/2015)... ... ... An inventor from Gibertsville, Pa., knows how knees can get in the way ... trying to sleep," he said, "so I decided that there needs to be a ... KNEE GUARD helps a user get a better sleep by preventing the knees from ...
Breaking Medicine News(10 mins):Health News:Amica Unleashes 5 Tips for Safe Traveling with Pets 2Health News:Market Publishers Ltd and Black Swan Analysis Sign Partnership Agreement 2Health News:Market Publishers Ltd and Black Swan Analysis Sign Partnership Agreement 3Health News:California’s Largest Private Oncology Practice Serves 50,000 Patients in 8 years 2Health News:DuraSpace Selects Gunter Media Group, Inc. as a Registered Service Provider for VIVO 2Health News:DuraSpace Selects Gunter Media Group, Inc. as a Registered Service Provider for VIVO 3
... University Medical School in Durham, North Carolina and colleagues have ... pain. Patients who use religion or spirituality to cope with ... and boost their sense of well being, the researchers say. ... with chronic illness or chronic pain might find it difficult ...
... liver can injure the donor, it is now established without doubt ... to a person needing it. And the good news is that ... part of his/her liver. ,Donation of a piece of the ... new procedure. It is increasingly being performed in the West where ...
... research-cum-manufacturing agreement between Chiron Corp, the US-based vaccine major, ... potential AIDS vaccine to halt the spread of the ... stage of finalisation. ,Two Hyderabad-based biotechnology/pharma companies -- ... front-runners for the proposed project, which entails an upfront ...
... of the American Association of Endodontists in New Orleans, Louisiana, ... terse message, the dentists said that all toothache need not ... because it may be the early warning for more important ... hygiene has never received its due importance from the masses. ...
... the British government says that smoking will turn out to ... the threat of even HIV. The British broadcasting corporation reported ... more people than any other disease in the next 20 ... in Sussex, United Kingdom, says smoking and other tobacco related ...
... up to 3 million lives a year. WHO released a ... March. The report says most of those who die are ... the developing world are particularly at risk for water-borne diseases. ... contaminated water and 90% of those deaths are among children ...
Cached Medicine News:Health News:Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos 2
... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...
... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...
... The Blue Line UNO Splint fits small, medium, ... cushioned two-part design includes both dorsal and volar ... extension. Recommended for those experiencing symptoms of Carpal ... for busy clinics - stock one splint to ...
Comfort Wrist Immobilizer with thumb abduction. 8"L, soft, padded comfort-type wrist immobilizer with dorsal metal stay. The thumb is held in abduction and splintered with a short metal stay....
Medicine Products: